Celldex Therapeutics (CLDX) Amortization of Goodwill (2018)
Celldex Therapeutics (CLDX) recorded quarterly Amortization of Goodwill of -$24000.0 in Q2 2018, down 100.03% quarter-over-quarter from $91.0 million in Q1 2018.
Celldex Therapeutics (CLDX) Amortization of Goodwill (2018) Analysis & Trends
Celldex Therapeutics' Amortization of Goodwill history runs 1 years deep, the most recent figure standing at -$24000.0 for Q2 2018.
- In Q2 2018, Amortization of Goodwill changed N/A year-over-year to -$24000.0; the TTM figure through Dec 2018 stood at $91.0 million (changed N/A YoY), while the FY2018 annual figure was $91.0 million, changed N/A from the prior year.
- Amortization of Goodwill was -$24000.0 for Q2 2018 at Celldex Therapeutics, down from $91.0 million in the prior quarter.
- In the past five years, Amortization of Goodwill ranged from a high of $91.0 million in Q1 2018 to a low of -$24000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celldex Therapeutics | 2.16 Bn | 2.16 Bn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -24,000.00 |
| Jun 30, 2018 | -24,000.00 |
| Mar 31, 2018 | 91.00 Mn |
| Mar 31, 2018 | 91.00 Mn |